| Heparin Derived Oligosaccharides by Enzyme,
Acid & Alkali Cleavage |
| |
|
| |
|
Note: In each case (enzyme, acid and alkali) the predominant
disaccharide unit in each fraction is shown in square brackets. However,
each size class also contains oligosaccharides with the same degree of
polymerisation but with variations in degree and position of sulphation.
Dextra can provide custom services to subfractionate the
differentially-sulphated heparin oligosaccharides in any size class-please
enquire.
Heparinase I Derived Unsaturated
Oligosaccharides
This group of unsaturated oligosaccharides is produced by the partial
depolymerisation of Heparin using the enzyme heparinase I. This
cleaves Heparin between N-sulphated glucosamine (GlcNSO3) and
2-O-sulphated idurnate (IdoA, 2S). This method of cleavage results
in unsaturated oligosaccharides with uronate 2-O-sulphate (UA, 2S) at the
non-reducing end of the fragment. Unsaturation is present between
carbons 4-5 on this terminal uronate residue.
The individual products are separated by high resolution gel permeation
chromatography.
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tetradecasaccharide
(dp14) |
|
| | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mixed
Oligosaccharides (>dp26) |
|
| | |
| Nitrous Acid Derived Deaminated
Oligosaccharides from Heparin |
| |
|
These oligosaccharides are produced by partial deaminative scission
using nitrous acid. The oligosaccharides have either uronate
2-O-sulphate (shown below) or non sulphated uronate at the non-reducing
end of the fragment. Note that the end chain uronate structure is
not affected by nitrous acid but anhydromannose is produced at the
reducing end, which is subsequently reduced to anhydromannitol.
Below are shown examples of the oligomeric series which can be extended
in DP as for the enzyme and alkali-derived fractions. Please enquire
for availability and price of these and higher members of the series.
|
| |
|
|
|
|
| Alkali Derived Unsaturated
Oligosaccharides from Heparin |
| |
These oligosaccharides are produced by the beta eliminative
cleavage of the benzoyl ester of Heparin by alkali treatment. This
method of degradation is the chemical equivalent to heparinase I
digestion, but lacks the specificity of the enzyme. The resulting
oligosaccharides have uronate 2-O-sulphate (as shown) or non-sulphated
uronate at the non-reducing terminal. These oligosaccharides are
broadly similar to those produced by heparinase I but with potentially
interesting sequence variations. The fractions are separated by high
resolution gel permeation chromatography.
|
| |
|
|
|
|
|
|
|
|
|
|
Tetradecasaccharide
(dp14) |
|
| | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mixed
Oligosaccharides (>dp26) |
|
| | |